Skip to main content
. 2022 Jul 1;273(4):839–851. doi: 10.1007/s00406-022-01442-4

Table 6.

Significant predictors of weight change over time

ß t df p CI
FEV—disinhibition
Disinhibition change 4.12 2.80 7 0.027* [0.65; 7.68]
Disinhibition change × sex −1.63 −2.81 7 0.026* [−3.18; −0.27]
Disinhibition change × drug dosage  −1.25  −2.61 7 0.035* [−0.35; −0.02]
Disinhibition change × metSy  −1.19  −2.70 7 0.031* [−4.36; −0.29]
Food craving—sweets
Sweets craving change × sex 0.51 1.94 36 0.061+ [−0.02; 0.72]
Sweets craving change × drug dosage 0.56 1.96 36 0.057+ [− 0.002; 0.12]
Sweets craving change × metSy  −0.76 −1.88 36 0.068+ [−1.26; 0.05]
Food craving—fast food
Fast food craving change × drug dosage 0.71 2.96 40 0.005* [0.04; 0.19]
Food craving total score
Food craving × drug dosage 0.57 2.13 35 0.040* [0.001; 0.05]
Attitude towards drugs
Drug attitude change 3.48 3.35 34 0.002* [0.79; 3.23]
Drug attitude change × BMI −3.73 −3.19 34 0.003* [−0.13; −0.03]
Drug attitude change × drug dosage −0.85 −3.10 34 0.004* [−0.14; −0.03]
Drug attitude change × metSy 1.15 2.72 34 0.010* [0.34; 2.32]

metSy metabolic syndrome according to IDF [17]; × multiplicative operator indicating the interaction term; df degrees of freedom; CI 95% confidence interval; +p ≤ 0.10, *p ≤ 0.05.